Backs FY25 revenue view $1.37B, consensus $1.37B. The company said, “CONMED (CNMD) does not expect a material impact on its 2025 financial results and is reaffirming its prior guidance range for revenue and adjusted EPS.”
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CNMD: